BNT329 + CA19-9-targeting monoclonal antibody

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

BNT329 + CA19-9-targeting monoclonal antibody
Treatment and conditionWhere it standsTrials
BNT329 + CA19-9-targeting monoclonal antibody for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1